
AdvaMed’s Top 10 Medtech Wins in 2022
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel companies, 2022 was a…
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel companies, 2022 was a…
The Advanced Medical Technology Association (AdvaMed) this week concluded its annual The Medtech Conference, a content-packed three days in a return to fully in-person events. The Medtech Conference, regarded as…
This week, the Senate and House unanimously approved the reauthorization of the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs for three years. Since early 2021, AdvaMed…
AdvaMed Accel held the 3rd Quarter meeting of the Medtech Investment Working Group.
Juliana Elstad, President and CEO of Vibrato Medical, recently joined AdvaMed’s Scott Whitaker on The Medtech POV podcast for a conversation on several policy initiatives.
In recent years, private investors have been subject to increased government enforcement scrutiny under the False Claims Act. Given investors’ vital role in medtech, AdvaMed developed tools and resources to…
AdvaMed Accel held the 2nd Quarter meeting of the Medtech Investment Working Group.
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association (AdvaMed) released this statement from President and CEO Scott Whitaker.
Investment in early-stage medtech innovation can be critical in ensuring that patients have access to novel therapeutics and diagnostics.
The Q1 2022 meeting focuses on the diagnostics industry with presentations from Susan Van Meter, Executive Director of AdvaMedDx and a discussion panel on deal-making in diagnostics.